Goldman Analyst Says Myriad's Stock Buyback Strategy Suggests Slowing Organic Growth

A Goldman Sachs analyst said that Myriad's third share repurchase program in less than 12 months "is reflective of slowing organic growth and increasing dependence on financial engineering to drive bottom-line growth."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.